ROLE OF CD44 IN THE INVASIVENESS OF GLIOBLASTOMA-MULTIFORME AND THE NONINVASIVENESS OF MENINGIOMA - AN IMMUNOHISTOCHEMISTRY STUDY

被引:51
作者
ARIZA, A
LOPEZ, D
MATE, JL
ISAMAT, M
MUSULEN, E
PUJOL, M
LEY, A
NAVASPALACIOS, JJ
机构
[1] HOSP UNIV GERMANS TRIAS & PUJOL,DEPT NEUROSURG,E-08916 BADALONA,SPAIN
[2] UNIV AUTONOMA BARCELONA,HOSP SANTA CREU & SANT PAU,DEPT PATHOL,BARCELONA,SPAIN
[3] HOSP ESPERIT SANT,DEPT PATHOL,BARCELONA,SPAIN
[4] FDN ECHEVARNE,BARCELONA,SPAIN
关键词
CD44; MENINGIOMA; GLIOBLASTOMA MULTIFORME; INVASION; METASTASIS; IMMUNOHISTOCHEMISTRY;
D O I
10.1016/0046-8177(95)90278-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD44 is a polymorphic family of cell adhesion molecules that seems to be instrumental in the mechanism of tumor invasion and metastasis. Tumor cell expression of CD44, or lack thereof, may be one of the factors conditioning the highly disparate ability to penetrate the brain extracellular matrix (ECM) exhibited by glioblastoma multiforme (GM) and conventional meningioma. To assess the presence of CD44 in these two tumor types we have immunohistochemically investigated the expression of CD44 standard form (CD44s) and the variant isoforms containing the domain encoded by variant exon 3 (CD44v3) and variant exon 6 (CD44v6) in paraffin-embedded tissue from 10 conventional meningiomas and 10 GMs. A CD44s-/CD44v-phenotype was discerned in the meningioma cases, whereas GMs featured a CD44s+/CD44v- expression profile. Consequently, the growth patterns of meningioma and GM seem to be, at least in part, a reflection of their CD44 expression status. Paucity of CD44 in meningioma cells would render them unable to infiltrate the brain ECM, whereas CD44-rich glioma cells would successfully migrate through it. Conversely, lack of CD44v expression would contribute to explain the lack of metastatic potential characterizing both conventional meningioma and GM. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:1144 / 1147
页数:4
相关论文
共 24 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   HYALURONATE BINDING AND CD44 EXPRESSION IN HUMAN GLIOBLASTOMA CELLS AND ASTROCYTES [J].
ASHER, R ;
BIGNAMI, A .
EXPERIMENTAL CELL RESEARCH, 1992, 203 (01) :80-90
[3]  
CARTER WG, 1988, J BIOL CHEM, V263, P4193
[4]   CD44 AND CANCER SCREENING [J].
FOX, SB ;
GATTER, KC ;
JACKSON, DG ;
SCREATON, GR ;
BELL, MV ;
BELL, JI ;
HARRIS, AL ;
SIMMONS, D ;
FAWCETT, J .
LANCET, 1993, 342 (8870) :548-549
[5]   STRUCTURAL HOMOLOGY BETWEEN LYMPHOCYTE RECEPTORS FOR HIGH ENDOTHELIUM AND CLASS-III EXTRACELLULAR-MATRIX RECEPTOR [J].
GALLATIN, WM ;
WAYNER, EA ;
HOFFMAN, PA ;
STJOHN, T ;
BUTCHER, EC ;
CARTER, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4654-4658
[6]   LOCALIZATION OF THE CD44 GLYCOPROTEIN TO FIBROUS ASTROCYTES IN NORMAL WHITE MATTER AND TO REACTIVE ASTROCYTES IN ACTIVE LESIONS IN MULTIPLE-SCLEROSIS [J].
GIRGRAH, N ;
LETARTE, M ;
BECKER, LE ;
CRUZ, TF ;
THERIAULT, E ;
MOSCARELLO, MA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1991, 50 (06) :779-792
[7]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[8]  
JACKSON DG, 1993, LANCET, V341, P252, DOI 10.1016/0140-6736(93)90126-2
[9]   A DISTINCT ENDOTHELIAL-CELL RECOGNITION SYSTEM THAT CONTROLS LYMPHOCYTE TRAFFIC INTO INFLAMED SYNOVIUM [J].
JALKANEN, S ;
STEERE, AC ;
FOX, RI ;
BUTCHER, EC .
SCIENCE, 1986, 233 (4763) :556-558
[10]   HOMING RECEPTORS AND THE CONTROL OF LYMPHOCYTE MIGRATION [J].
JALKANEN, S ;
REICHERT, RA ;
GALLATIN, WM ;
BARGATZE, RF ;
WEISSMAN, IL ;
BUTCHER, EC .
IMMUNOLOGICAL REVIEWS, 1986, 91 :39-60